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In Brief
Inhibitory neurons are heterogeneous,
but how individual subtypes contribute to
behavior is unknown. Here, Ito-Ishida
et al. show that dysfunction of the two
most populous subtypes, PV+ and SOM+
neurons, cause distinct, non-overlapping
behavioral phenotypes that recapitulate
global Mecp2 loss.
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Inhibitory neurons are critical for proper brain func-
tion, and their dysfunction is implicated in several
disorders, including autism, schizophrenia, and
Rett syndrome. These neurons are heterogeneous,
and it is unclear which subtypes contribute to spe-
cific neurological phenotypes. We deleted Mecp2,
the mouse homolog of the gene that causes Rett
syndrome, from the two most populous subtypes,
parvalbumin-positive (PV+) and somatostatin-posi-
tive (SOM+) neurons. Loss ofMeCP2 partially impairs
the affected neuron, allowing us to assess the func-
tion of each subtype without profound disruption
of neuronal circuitry. We found that mice lacking
MeCP2 in either PV+ or SOM+ neurons have distinct,
non-overlapping neurological features: mice lacking
MeCP2 in PV+ neurons developed motor, sensory,
memory, and social deficits, whereas those lacking
MeCP2 in SOM+ neurons exhibited seizures and ste-
reotypies. Our findings indicate that PV+ and SOM+
neurons contribute complementary aspects of the
Rett phenotype and may have modular roles in regu-
lating specific behaviors.
INTRODUCTION
Rett syndrome (RTT) is a devastating postnatal neurodeve-
lopmental disorder caused by mutations in the gene encoding
methyl-CpG binding protein 2 (MeCP2) (Amir et al., 1999).
Affected children appear to develop normally during the first
year of life but quickly regress, losing language and acquired
motor skills and developing ataxia, respiratory dysrhythmias,
seizures, cognitive deficits, and stereotyped hand movements
(Chahrour and Zoghbi, 2007). Because the RTT phenotype is
so broad, several conditional knockout mice have been gener-ated to dissect the contribution of various brain regions and
neuronal subtypes to the pathogenesis of the disorder. For
instance, mice with Mecp2 conditionally deleted from the me-
dulla and spinal cord reproduce the respiratory dysrhythmias
and premature death (Ward et al., 2011), while a forebrain excit-
atory neuron deletion mouse develops seizures (Zhang et al.,
2014). Unexpectedly, depleting MeCP2 in inhibitory neurons
using a Viaat-Cre allele that targets GABAergic neurons recapit-
ulates almost the entire spectrum of RTT features, including
motor, sensory, memory, social, and autonomic dysfunction as
well as stereotyped behaviors (Chao et al., 2010). These results
underscore the importance of MeCP2 for the function of inhibi-
tory neurons and the breadth of neurological consequences
that follow moderate compromise of inhibitory signaling.
The various interneuron subtypes, which exhibit a striking
range of morphological, electrophysiological, and molecular
properties, seem to possess distinct circuit functions (Kepecs
and Fishell, 2014; Klausberger and Somogyi, 2008) and appear
to be recruited by different behavioral events (Kvitsiani et al.,
2013; Wolff et al., 2014). For instance, parvalbumin-positive
(PV+) and somatostatin-positive (SOM+) neurons, which each
constitute 30%–40% of the entire inhibitory neuronal popula-
tion in the cortex (Rudy et al., 2011), have been implicated in
different stages of foraging behavior, regulated by the anterior
cingulate cortex, and have different functions in the amygdala
during cued memory (Kvitsiani et al., 2013; Wolff et al., 2014).
To better understand how these two subpopulations individually
contribute to complex behaviors in vivo, it would be ideal to
partially disable their function rather than ablate them, so as to
avoid the confound of widespread cell death or complete
collapse of the neural circuit.
Because loss of MeCP2 creates just such a partial dysfunction
of the affected neuron, we conditionally deleted Mecp2 from
PV+ neurons and from SOM+ neurons to explore the behavioral
consequences. While neither conditional knockout mouse
developed the full array of constitutiveMecp2-deletion features,
the two lines together recapitulated many of the Rett-like pheno-
types: the PV conditional knockouts developed motor, sen-
sory, social, and cognitive deficits, while the SOM conditionalNeuron 88, 651–658, November 18, 2015 ª2015 Elsevier Inc. 651
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knockout mice exhibited repetitive behaviors and seizures.
These two models reinforce the importance of a robust function-
ality of these neurons for normal behavior.
RESULTS
MeCP2 Is Expressed Both in PV+ and SOM+ Neurons in
Various Brain Regions
To confirm that MeCP2 is expressed in PV+ and SOM+ neurons,
we stained brain sections from adult SOM-Cre: Ai9 mice, which
express a tdTomato reporter in SOM+ neurons, with antibodies
for MeCP2 and PV. Both PV+ and SOM+ neurons expressed
MeCP2 in various brain regions (Figure 1A). MeCP2 signal was
comparable between PV+ and SOM+ neurons in the CA1 region
of the hippocampus (n = 5mice, p = 0.96, paired t test) and in the
striatum (n = 5 mice, p = 0.19, paired t test), while the signal was
somewhat stronger in SOM+ neurons in the cortex (layer 2/3, n =
5 mice, p = 0.013, paired t test) (Figure 1B). We also confirmed
that there was little overlap between PV+ and SOM+ cells, which
was consistent with previous reports (Rudy et al., 2011); cells
expressing both PV and SOM accounted for 3.7% ± 2.8% of
neurons in the cortex (layer 2/3) and 5.7% ± 2.8% in the hippo-
campus (CA1) (n = 5 mice); however, these values may be
overestimated, as the SOM-Cre:Ai9 line labels SOM+ cells
throughout development.
PV+ and SOM+ Neurons Lacking MeCP2 Produce
Distinct Neurological Phenotypes
To determine the contributions of PV+ and SOM+ neurons to the
behavioral features observed in Viaat-Mecp2-/y mice (Chao
et al., 2010), we generated two lines of conditional knockout
mice lacking MeCP2 in either PV+ neurons (PV-Mecp2-/y) or
SOM+ neurons (SOM-Mecp2-/y) by crossing Mecp2flox/+ mice
(Flox) (Guy et al., 2001) to PV-Cre (Madisen et al., 2010) and
SOM-Cre (Taniguchi et al., 2011) mice, respectively. PV-
Mecp2-/y and SOM-Mecp2-/y mice initially appeared similar to
littermate control mice. Immunofluorescence staining confirmed
MeCP2 expression was effectively depleted in PV+ and SOM+
cells, respectively (Figures 1C–1E). The expression of MeCP2
in SOM+ cells of PV-Mecp2-/y brains and in PV+ cells of SOM-
Mecp2-/y mice was unaltered, indicating no compensation of
Mecp2 expression in the unmanipulated inhibitory neuron sub-
types (Figure S1).
We next characterized PV-Mecp2-/y and SOM-Mecp2-/y mice
usingmultiple behavioral assays. Because theMecp2flox/y condi-Figure 1. MeCP2 Is Expressed Both in PV+ and SOM+ Neurons
(A) MeCP2 is expressed by both PV+ neurons (green arrows) and SOM+ neur
hypothalamus, and cerebellum of 4-month-old SOM-Cre:Ai9 mice expressing td
(green).
(B) MeCP2 levels in PV+ and SOM+ neurons in three brain regions. Relative MeCP
PV- and SOM-negative cells. MeCP2 intensity was slightly higher in SOM+ neuron
hippocampus and the striatum. n = 5 mice per genotype.
(C) Representative images of brain slices from 4-month-old PV- and SOM-Mecp
nofluorescence. SOM+ neurons were identified by crossing mice to Ai9 mice to in
PV+ or SOM+ cells (arrows).
(D and E) Ratio of MeCP2-positive cells among PV+ (D) and SOM+ (E) neurons
represent mean ± SEM. *p < 0.05. Paired t test. See also Figure S1. Scale bar =tional allele causes a constitutive 50% reduction ofMeCP2 levels
(Samaco et al., 2008), we expected the Floxmice to differ slightly
fromwild-type as the animals age; we therefore analyzed all data
by comparing conditional knockout mice with male littermates of
three control groups: wild-type (WT), PV-Cre alone or SOM-Cre
alone, and Mecp2flox/y alone (Flox).
Interestingly, PV-Mecp2-/y and SOM-Mecp2-/y mice devel-
oped completely different neurological deficits. PV-Mecp2-/y
micedevelopedprogressive ataxia, as shownby reduced latency
to fall in both the rotarod (Figures 2A and 2B) and dowel walk
assays (Figure 2C). The ataxia was apparent at 6 weeks and
worsened by 20 weeks (Figures 2A and 2B). Consistent with
this observation, PV-Mecp2-/y mice developed widely splayed
hind limbs after 10 weeks (Figures S2A and S2B) and hind limb
retraction after 15 weeks of age (Figure 2D); they also showed
impaired performance on the marble-burying test, suggesting
forelimb incoordination (Figure S2C). The SOM-Mecp2-/y mice
displayed none of these motor deficits (Figures 2E–2H and
Figure S2D).
PV-Mecp2-/y mice also exhibited sensory, memory, and
cognitive impairments that were not apparent in SOM-Mecp2-/y
mice (Figure 3). PV-Mecp2-/y mice had a significantly diminished
acoustic startle response (Figure 3A) and spent significantly
more time interacting with novel partner mice in a social behavior
assay (Figure 3B). In addition, PV-Mecp2-/y mice developed
progressive cued memory deficits (Figures 3C and 3D). The
difference in freezing response to a conditioned tone between
PV-Mecp2-/y and each of the three control groups became
statistically significant at 15 weeks of age (Figures 3C and 3D).
In contrast, SOM-Mecp2-/y mice did not show alterations in
acoustic startle response, partition, or cued memory tests (Fig-
ures 3E–3H).
The PV-Mecp2-/y mice thus reproduced many of the features
observed in the Mecp2 null and Viaat-Mecp2-/y male mice
(Chao et al., 2010), but they did not reproduce the stereotyped
behaviors (Figure 4A) or seizures. These two features were
prominent, however, in the SOM-Mecp2-/y mice (Figures 4B
and 4C). Like the Viaat-Mecp2-/y mice, SOM-Mecp2-/y mice
showed repetitive nose-poking behavior in the hole board test
(Figure 4B) (Chao et al., 2010). Fifty percent of SOM-Mecp2-/y
mice developed spontaneous epileptic seizures starting at
12 weeks (Figure 4C), with generalized tonic clonic seizures
observed during routine handling (Movie S1). There was only
one RTT-related feature that the PV-Mecp2-/y and SOM-
Mecp2-/y mice shared: both conditional knockout lines diedons (red arrowheads) in the cortex (layer 2/3), hippocampus (CA1), striatum,
Tomato in SOM+ neurons (red) and immunostained for MeCP2 (blue) and PV
2 intensity in PV+ and SOM+ cells was quantified by normalizing the intensity to
s in the cortex, while the intensity was similar in PV+ and SOM+ neurons in the
2-/y mice, immunostained for MeCP2. PV+ neurons were visualized by immu-
duce TdTomato expression. MeCP2 signal was significantly reduced in either
in PV- and SOM-Mecp2-/y mice, respectively. n = 3 mice per genotype. Bars
20 mm.
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Figure 2. Depletion of MeCP2 in PV+ but Not in SOM+ Neurons Causes Motor Dysfunction
(A and B) PV-Mecp2-/y mice showed progressive impairment in rotarod performance. The latency to fall was decreased in PV-Mecp2-/y mice at 6 weeks but was
statistically significant for only two trials (A). The decrease was significant between PV-Mecp2-/y and controls for 7 of 8 trials at 20 weeks (B).
(C) Time on the dowel was decreased at 9 weeks in PV-Mecp2-/y mice.
(D) PV-Mecp2-/y mice developed clear hind limb retraction after 15 weeks.
(E–G) SOM-Mecp2-/y mice displayed nomotor dysfunction on the rotarod (E and F) or dowel (G). The latency to fall from the rotarod was significantly decreased in
both Flox and SOM-Mecp2-/y at 19 weeks while there was no difference between Flox and SOM-Mecp2-/y (F). The differing baselines at 19–20 weeks is likely due
to two independent cohorts of PV-Mecp2-/y mice being used to test rotarod at 6 weeks and 20 weeks versus the same cohort of SOM-Mecp2-/y mice used for
both time points.
(H) SOM-Mecp2-/y mice showed no hindlimb clasping.
Bars represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, #p < 0.0001. Numbers in graphs represent number of mice (n) per genotype. See also Figure S2.prematurely, with 50%mortality by 29–35 weeks of age (Figures
4D and 4E).
PV+ and SOM+Neurons Are Responsible for theMajority
of RTT-like Features Observed in Viaat-Mecp2-/y Mice
The above behavioral studies reveal that PV-Mecp2-/y and SOM-
Mecp2-/y mice develop complementary aspects of the RTT
phenotype, together recapitulating the majority of the Viaat-
Mecp2-/y mouse phenotype (Table 1). Neither the PV-Mecp2-/y
nor the SOM-Mecp2-/y mice developed any deficits that were
not observed in Viaat-Mecp2-/y mice, such as anxiety behaviors
as measured in the light/dark and elevated plus maze tests (Fig-
ures S3A–S3D). It is worth noting, however, that these two lines
failed to develop three features exhibited by the Viaat-Mecp2-/y
mice (Chao et al., 2010): increased pre-pulse inhibition, reduced
locomotor activity, or increased body weight (Figures S3E–S3J).
We also found that long-term potentiation (LTP) in theCA1 region
of hippocampus was not altered in either conditional knockout
(data not shown). It thus seems likely that some features of
Viaat-Mecp2-/y mice are mediated by another inhibitory neuron
subtype (such as glycinergic neurons, which also express the
Viaat transporter) or that synergistic impairment of multiple inhib-
itory neurons is necessary for some RTT symptoms to appear.654 Neuron 88, 651–658, November 18, 2015 ª2015 Elsevier Inc.DISCUSSION
Loss-of-function mutations in MECP2 cause a broad array of
neuropsychiatric symptoms, indicating that MeCP2 is critical
for normal brain function and behavior (Chahrour and Zoghbi,
2007; Chao and Zoghbi, 2012). TheMecp2-heterozygous female
mouse reproduces many features of the human disease, such
as ataxia, breathing abnormalities, abnormal sensory function,
learning and memory deficits, and abnormalities in social
behavior (Samaco et al., 2013); the Mecp2 null male mouse de-
velops an accelerated and more severe version of the disorder
(Baker et al., 2013; Chen et al., 2001; Guy et al., 2001; Heckman
et al., 2014). Strikingly, most of these RTT-like features can be
replicated by eliminating MeCP2 from GABAergic neurons
(Chao et al., 2010), which make up approximately 20% of the
neurons in the brain. The heterogeneity of this cellular population
led us to investigate the contributions of the different subtypes of
inhibitory neurons to the pathogenesis of RTT. Here, we show
that the two largest subtypes of GABAergic neurons, PV+ and
SOM+ neurons, each contribute distinct features to the pheno-
type of the Viaat-Mecp2-/y mice (Chao et al., 2010) and thus
to the major features of RTT (Table 1). It is possible that some
subtle phenotypic abnormalities are present in both conditional
Figure 3. Depletion of MeCP2 in PV+ but Not in SOM+ Neurons Causes Sensory, Social, and Memory Deficits
(A) PV-Mecp2-/y mice showed decreased acoustic startle response. Average startle response was decreased in Flox compared to WT and PV-Cre. It was further
decreased in PV-Mecp2-/y mice, and the difference was significant between all three control groups.
(B) PV-Mecp2-/y mice spent more time interacting with novel partners than their littermates in the partition test. While the interaction time of Flox was higher than
those of WT or PV-Cre mice, PV-Mecp2-/y mice showed an increase in the interaction time when compared to all three control groups, including Flox.
(C and D) PV-Mecp2-/y mice showed progressive cuedmemory deficits. Freezing response of PV-Mecp2-/y mice was decreased compared toWT but was similar
to PV-Cre and Flox at 10 weeks (C). The response was significantly decreased in PV-Mecp2-/y compared to all control groups at 15 weeks (D).
(E) SOM-Mecp2-/y mice did not show deficits in acoustic startle response. Average startle response of SOM-Mecp2-/y was lower compared to WT and SOM-Cre
but was similar to Flox.
(F–H) SOM-Mecp2-/y mice did not show deficits in social interaction (F) or cued memory (G and H). Freezing response to tone was decreased in SOM-Mecp2-/y
compared to WT at 10 weeks and SOM-Cre at 15 weeks but was similar to Flox at both 10 weeks and 15 weeks (G and H).
Bars represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, #p < 0.0001. Numbers in graphs represent number of mice (n) per genotype.knockout models but were obscured due to comparison with the
Flox mice, which express 50% less MeCP2 and show some
behavioral changes when compared to wild-type mice, espe-
cially as they age. However, even when taking this into consider-
ation, the contrasting features of the PV- and SOM- Mecp2-/y
were clear and confirmed using multiple behavioral tests, sug-
gesting that these two neuronal subtypes play distinct roles in
the pathogenesis of RTT.
Disruptions in inhibitory neuron function have been postulated
to contribute to several neurodevelopmental disorders, including
autism and schizophrenia (Le Magueresse and Monyer, 2013;
Penzes et al., 2013); our studies suggest that dysfunction of
specific inhibitory neuron subtypes probably underlies specific
symptoms in these disorders. Recent work using optogenetics
has revealed that PV+ and SOM+ cells in a local circuit are
activated differently during foraging behavior and acquisition of
fear conditioning (Kvitsiani et al., 2013; Wolff et al., 2014). Our
findings using partial impairment of these neurons suggest addi-
tional functional roles, with PV+ neurons critical for motor and
higher cognitive functions and SOM+ neurons contributing to
seizure susceptibility and stereotypic behaviors. Given that
most neuropsychiatric disorders do not involve total loss of aneuronal subtype and/or its function but rather are due to subtle
impairment of one or more neuronal subtypes, our study sheds
light on the neuroanatomical bases of some human neuropsychi-
atric phenotypes. Neuropsychiatric disorders that share symp-
toms with RTT might well involve dysfunction of PV+ and/or
SOM+ neurons.
PV+ and SOM+ inhibitory neurons are both widely distributed
throughout the brain but differ in their firing patterns and inner-
vation targets: PV+ neurons tend to be fast spiking and synapse
onto the soma and axon initial segment of their target neurons,
while SOM+ neurons spike more slowly and target dendrites
(Kepecs and Fishell, 2014). Because MeCP2 is expressed in
both neuronal subtypes and throughout the brain (Figures 1A
and 1B), the distinct behavioral features of PV-Mecp2-/y and
SOM-Mecp2-/y mice cannot be explained by regional differences
in MeCP2 expression. It is, however, intriguing that MeCP2 may
be more highly expressed in SOM+ neurons in the cortex, sug-
gesting thatMeCP2 expression levels may contribute to different
properties of neuronal subtypes (Figure 1B). It is also worth
noting that PV-Mecp2-/y mice developed a wide range of
RTT-related features (motor, sensory, social, and cognitive def-
icits), while SOM-Mecp2-/y mice seemed to be deficient in theNeuron 88, 651–658, November 18, 2015 ª2015 Elsevier Inc. 655
Figure 4. Depletion ofMeCP2 in SOM+Neu-
rons Causes Seizures and Stereotyped
Behavior, whereas Loss of MeCP2 in either
PV+ or SOM+ Neurons Causes Premature
Lethality
(A) PV-Mecp2-/y mice did not show repetitive nose
poking in the hole board assay.
(B) SOM-Mecp2-/y mice showed repetitive nose
poking to the same holes in the hole board assay.
The frequency of sequential nose pokes was
significantly higher in SOM-Mecp2-/y than in all
three control groups.
(C) SOM-Mecp2-/y mice showed generalized sei-
zures after 12 weeks. The graph shows incidence
of seizures (n = 14–25 mice per time point).
(D and E) Both PV-Mecp2-/y (D) and SOM-
Mecp2-/y (E) male mice die prematurely. Half of the
mice died by 30 weeks of age.
Bars represent mean ±SEM. ***p < 0.001. See also
Movie S1.modulatory functions of inhibitory neurons, developing seizures
and stereotypies. That PV-Mecp2-/y mice seem to be more
severely affected could reflect the greater role of PV+ cells in
suppressing pyramidal cell output (Atallah et al., 2012). The
stronger neurological phenotype of PV-Mecp2-/y mice could
also reflect the integral role of PV+ neurons in maintaining excit-
atory/inhibitory balance in the cortex, a role that SOM+ neurons
do not share (Xue et al., 2014).
Recent work by He et al. showed that loss of MeCP2 from PV+
neurons resulted in cells with immature neuronal properties,
leading to decreased sensitivity to excitatory input (He et al.,
2014); aMecp2 null PV+ neuron may be unable to assess down-
stream excitatory neuronal activity and modulate its inhibitory
activity appropriately. The authors also performed a limited num-
ber of behavioral analyses of mice lacking MeCP2 in PV+ cells,
but their results showed only amild ataxia and no effect on social
interaction or cued memory. The more extensive phenotypes
seen in our study are most likely due to the difference in the
animal’s age: He et al. evaluated the mice at a younger age
(8–10 weeks), while we studied them longitudinally over an
extended period and observed memory and social deficits at
15 and 14 weeks, respectively. It is also important to consider
the differences in expression patterns between the utilized Cre
lines: He et al. used a Pvalb-IRES-Cre mouse line, which ex-
presses Cre only in neurons that strongly express PV but does
not cover a large population of more weakly PV-expressing neu-
rons, such as those in the inner nuclei of the thalamus, which are
targeted by the Pvalb-2A-Cre line used here (Madisen et al.,
2010). It has been shown that cells expressing a low level of
PV, including some layer 5 pyramidal cells, also express Cre in
the Pvalb-2A-Cre line (Madisen et al., 2010), and we cannot
exclude the possibility that some features observed were
confounded by the deficit in layer 5 pyramidal cells. This possi-656 Neuron 88, 651–658, November 18, 2015 ª2015 Elsevier Inc.bility is unlikely, however, as CamKII-
Cre; Mecp2flox/y mice (CamKII-Mecp2-/y)
(Chen et al., 2001; Gemelli et al., 2006),
which lack Mecp2 in forebrain excitatory
neurons, show only limited behavioralabnormalities, whereas Viaat-Mecp2-/y mice recapitulate the
majority of RTT-related features without affecting Mecp2
expression in layer 5. In addition, Viaat- and PV-Mecp2-/y show
increased social interaction, a severe motor deficit, but no anxi-
ety, whereas CamKII-Mecp2-/y mice show anxiety, decreased
social interaction, and only mild ataxia in the rotarod assay.
Although neurological features in PV-Mecp2-/y and SOM-
Mecp2-/y mice recapitulated the majority of behavioral deficits
observed in Viaat-Mecp2-/y mice, this replication was not com-
plete (Table 1 and Figure S3). It thus seems likely that either
another inhibitory neuron subtype mediates the remaining three
features or that synergistic impairment of multiple cell types
is necessary for some RTT symptoms to appear. Some of the
features absent from both PV-Mecp2-/y and SOM-Mecp2-/y
mice could be attributed to the medium spiny neurons in the
striatum, which are inhibitory projection neurons expressing
Viaat but not PV or SOM, or to 5HT3a receptor-expressing inhib-
itory neurons, which constitute about 30% of the interneurons in
the cortex but do not overlap with PV+ or SOM+ interneurons
(Fe´re´zou et al., 2002; Rudy et al., 2011). One subtype of 5HT3a
receptor+ cells, vasoactive intestinal peptide-expressing cells,
is activated during auditory discrimination tasks, whisking, and
other behaviors and serves primarily to innervate SOM+ cells
in the cortex to disinhibit local circuitry (Lee et al., 2013; Pi
et al., 2013). It would be of great interest to investigate the role
of 5HT3a receptor+ cells in behavior and in the pathogenesis
of RTT.
The only common feature observed both in PV-Mecp2-/y and
SOM-Mecp2-/y mice was early death, suggesting that robust
function of both PV+ and SOM+ neurons are critical for survival
(Figures 4D and 4E). Re-expressing MeCP2 only in PV+ or in
SOM+ cells of Mecp2 null mice improves gross phenotypic
score and survival rate, while such improvement is not observed
Table 1. Phenotypic Consequences of Depleting MeCP2 in
Inhibitory Neurons
Feature
Viaat-
Mecp2-/y
PV-
Mecp2-/y
SOM-
Mecp2-/y
Median Survival 26 weeks 30 weeks 35 weeks
Motor Incoordination Y Y 
Spasticity + + 
Altered Startle Response Y Y 
Learning and Memory
Deficit
Y Y 
Altered Social Interaction [ [ 
Stereotypy [  [
Seizures +  +
Activity Changes Y  
Sensorimotor Gating
Defect
[  
Obesity +  
PV-Mecp2-y and SOM-Mecp2-y showed specific subsets of neurological
features observed in Viaat-Mecp2-y mice. See also Figures S2 and S3.in mice expressing MeCP2 only in the forebrain inhibitory neu-
rons (Goffin et al., 2014). Loss of MeCP2 in the brain stem and
spinal cord causes abnormal respiration and heart rate and is
associated with premature death (Ward et al., 2011). It thus
seems likely that PV+ or SOM+ cells in the hindbrain regions or
the spinal cord are critical for normal lifespan, although the direct
cause of premature lethality in Mecp2 null mice is still unclear.
Further study is necessary to distinguish the physiological func-
tions of PV+ and SOM+ cells in these brain regions.
How does MeCP2 loss in PV+ and SOM+ cells lead to neuro-
logical deficit? Because MeCP2 regulates expression of gluta-
mic acid decarboxylase (GAD), the phenotypes of PV- and
SOM- Mecp2-/y mice may be caused by partial loss of GAD
function (Chao et al., 2010). This seems unlikely, as only a few
features in the inhibitory neuron Mecp2 conditional knockout
are present in GAD2 knockout mice, and other phenotypes
do not overlap with either GAD1- or GAD2-deficient mice. While
GAD1 knockout mice die postnatally from a severe reduction in
GABA and cleft palate (Asada et al., 1997), GAD1 heterozygous
mice are viable and have reduced sociability (Sandhu et al.,
2014). GAD2 knockout mice are viable with only mild reduction
in GABA and develop spontaneous seizures, anxiety-related fea-
tures, impaired cued and contextual memory, and decreased
prepulse inhibition (Heldt et al., 2004; Kash et al., 1997, 1999;
Stork et al., 2003), but GAD2 heterozygotes are grossly normal
(Heldt et al., 2004; Kash et al., 1997). Therefore, the behavioral
effects must be due to some other cause beyond the partial
reduction in GAD1/2 levels. MeCP2 binds to DNA genome-
wide and regulates the expression of thousands of genes (Chah-
rour et al., 2008; Skene et al., 2010). It is thus likely that altera-
tion of many genes in addition to GAD1/2 causes widespread
neuronal dysfunction that leads to the behavioral effects of
MeCP2 loss.
In conclusion, our data indicate that individual inhibitory inter-
neuron subtypes contribute to the RTT phenotype in a somewhat
modular manner. Further characterization of the contribution ofthese two subtypes to behavior in health and disease should
shed light on a number of neuropsychiatric conditions.
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